Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call highlights record performance, strong international growth, and product diversification, with positive outlooks on new offerings like FX Spot+ and BrokerTec Chicago. Despite some concerns about tariffs and expenses, management's responses indicate effective risk management and strategic investments, supporting a positive sentiment.
Average Daily Volume (ADV) 30.2 million contracts, an increase of 16% year-over-year. Reasons: Broad-based growth across all 6 asset classes, heightened headline risk, macro uncertainties, and increased client preference for transparency and capital efficiency.
Financial Products Volume Grew by 17% year-over-year. Reasons: Increased demand for risk management products.
Commodity Sector Volume Grew by 15% year-over-year. Reasons: Increased demand for risk management products.
Open Interest Up by 7% from the end of Q2 2024 and 10% from year-end 2024. Reasons: Risk-on environment and growth in large open interest holders.
International Business Volume 9.2 million contracts per day, up 18% year-over-year. Reasons: Growth across all asset classes and customer segments, with record volumes in EMEA (up 15%) and APAC (up 30%).
New Retail Traders Over 90,000 new retail traders, a 56% increase year-over-year. Reasons: Growing focus on retail traders and partnerships with large retail broker partners.
Revenue $1.7 billion, up 10% year-over-year. Reasons: Record clearing and transaction fees and strong demand for risk management products.
Clearing and Transaction Fees $1.4 billion, up 11% year-over-year. Reasons: Record average rate per contract of $0.69.
Market Data Revenue $198 million, up 13% year-over-year. Reasons: Strong demand for market data.
Adjusted Operating Income $1.2 billion, up 14% year-over-year. Reasons: Strong cost discipline and increased revenue.
Adjusted Operating Margin 71%, up from 69.1% year-over-year. Reasons: Strong cost discipline and increased revenue.
Adjusted Net Income $1.1 billion, up 16% year-over-year. Reasons: Strong demand for risk management products.
Adjusted Diluted Earnings Per Share $2.96 per share, up 16% year-over-year. Reasons: Strong demand for risk management products.
Capital Expenditures $19 million for the quarter. Reasons: Not explicitly mentioned.
Cash $2.2 billion at the end of the quarter. Reasons: Not explicitly mentioned.
Dividends Paid $455 million in Q2 and approximately $3 billion over the first half of the year. Reasons: Not explicitly mentioned.
Micro E-mini NASDAQ 100 futures: Achieved a record of 4.1 million contracts in Q2, with 1.7 million contracts contributed by Micro E-mini NASDAQ 100 futures. NASDAQ 100 futures and options trading volume climbed to more than 2.5 million contracts per day, up 22% year-over-year.
NASDAQ 100 and other NASDAQ indexes license extension: Secured a 10-year extension of the exclusive license to offer futures and options on NASDAQ indexes, valid through 2039.
International business growth: Achieved highest-ever quarterly volume with 9.2 million contracts per day, up 18% year-over-year. EMEA volume grew by 15% to 6.7 million contracts per day, and APAC volume grew by 30% to 2.2 million contracts per day.
Retail trader participation: Over 90,000 new retail traders joined in Q2, a 56% increase year-over-year, contributing to the growth in Micro's ADV.
Financial performance: Generated $1.7 billion in revenue, up 10% year-over-year. Achieved record clearing and transaction fees of $1.4 billion and market data revenue of $198 million, up 13%.
Cost management: Adjusted expenses were $491 million, with an adjusted operating margin of 71%, up from 69.1% last year.
Focus on risk management: Broad-based growth in all six asset classes, with financial products volume up 17% and commodity sector volume up 15%. Open interest increased by 7% from Q2 2024 and 10% from year-end 2024.
Market Conditions: The company operates in an environment of heightened headline risk and macro uncertainties, which could impact client behavior and demand for products.
Regulatory Risks: Forward-looking statements involve risks, uncertainties, and assumptions that are difficult to predict, potentially affecting performance.
Strategic Execution Risks: The company’s growing focus on retail traders and international markets requires effective execution to sustain growth and manage operational complexities.
Economic Uncertainties: Economic uncertainties could influence the demand for risk management products and overall market activity.
Competitive Pressures: The company faces competitive pressures in maintaining exclusive licenses and expanding its product offerings to meet diverse customer needs.
Adjusted Operating Expenses: CME Group now expects total adjusted operating expenses for the year, excluding license fees, to be approximately $1.635 billion. This is $15 million below prior guidance and represents 3% growth from last year's adjusted expense levels.
Dividends Paid in Q2 2025: $455 million
Dividends Paid in H1 2025: Approximately $3 billion
The earnings call summary and Q&A session reveal several positive aspects: a strategic partnership with FanDuel, stable energy volumes, and significant proceeds from the OSTTRA sale. Although there are some uncertainties regarding sports-related contracts and parlays, the overall sentiment remains positive due to strong market data revenue growth and plans for 24/7 crypto trading. The slight reduction in operating expense guidance further supports a positive outlook. Despite some vague responses, the overall market strategy and shareholder return plans suggest a positive stock price movement.
The earnings call highlights record performance, strong international growth, and product diversification, with positive outlooks on new offerings like FX Spot+ and BrokerTec Chicago. Despite some concerns about tariffs and expenses, management's responses indicate effective risk management and strategic investments, supporting a positive sentiment.
The earnings call revealed strong financial performance with increased revenue, EPS, and operating income, alongside improved margins. The Q&A session highlighted growth in international markets and effective cost management, although some concerns were raised about management's clarity on certain issues. Despite this, the overall sentiment remains positive due to robust financial metrics and strategic initiatives like the BrokerTec launch, suggesting a likely stock price increase in the short term.
The earnings call highlights record revenue and net income, strong growth in risk management products, and increased client acquisition, particularly from international markets. The partnership with Google Cloud and significant increases in futures volumes due to Bitcoin and Ethereum ETFs are positive indicators. Despite some competitive pressures and regulatory risks, the optimistic guidance, robust financial performance, and active shareholder return strategies, including buybacks, suggest a positive outlook for the stock price over the next two weeks.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.